Huge Investment in Cardiac Arrest Treatment Market Expected to Witness the Highest Growth 2025 | GE, J&J, Abbott, Amgen, Pfizer, Novartis, Bristol-Myers Squibb, Boston Scientific, Bayer

Global Cardiac Arrest Treatment Market Synopsis:

The report covers a forecast and an analysis of the Cardiac Arrest Treatment Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Cardiac Arrest Treatment Market along with the impact they have on the demand over the forecast period.

Some of the most important key factors driving the growth of the Global Cardiac Arrest Treatment Market are rapid growth in cardiovascular diseases, increasing sedentary lifestyle, rising the geriatric population and the presence of research activities. As per the World Health Organization (WHO), around 17.9 million people die of cardiovascular diseases, every year, an estimated 31% of all the deaths worldwide. Four out of five CVD deaths are due to heart attacks and strokes. According to the World Journal of Cardiovascular Diseases, more than 7 million deaths are due to the sudden cardiac arrest across the globe each year. Thus, the growing number of heart failures, heart attacks, strokes, and other heart-related illness are driving the growth of Global Cardiac Arrest Treatment Market.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/252280 .

In terms of the regional analysis, the North America is dominating the Global Cardiac Arrest Treatment Market in 2018 and is estimated to hold significant market size over the forecast period (2020-2025) owing to the high adoption rate of CRT for cardiac arrest treatment among cardiologists and heart specialists and the presence of a large number of AED centers. Growing incidence of cardiovascular disorders and the advancements in medical devices for the treatment of cardiac arrest are expected to boost the market.

This report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the Global Cardiac Arrest Treatment Market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.

Global Key Players:

1 Amgen

2 Pfizer

3 Johnson & Johnson

4 Novartis AG

5 Bristol-Myers Squibb Company

6 Abbott

7 Koninklijke Philips

8 GE Healthcare

9 Physio-Control, Inc.

10 Boston Scientific Corporation

11 Cardiac Science Corporation

12 Shenzhen Mindray Bio-Medical Electronics

13 Bayer AG and More..............

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Cardiac Arrest Treatment Market Report 2020" @ https://www.businessindustryreports.com/buy-now/252280/single .

Product Type Segmentation

1 Drugs

2 Medical

Industry Segmentation

1 Hospitals

2 Independent Pharmacies

On the basis of Regional analysis, North America and Europe holds major share in global Cardiac Arrest Treatment market. Moreover, Asia-Pacific is expected to record higher growth rate in Cardiac Arrest Treatment Market during the forecast year.

Global Medical Industry News:

Abbott (March 27, 2020) - Abbott Launches Molecular Point-Of-Care Test to Detect Novel Coronavirus in As Little As Five Minutes - Abbott announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the company's ID NOW platform, providing rapid results in a wide range of healthcare settings such as physicians' offices, urgent care clinics and hospital emergency departments.

The ID NOW platform is small, lightweight (6.6 pounds) and portable (the size of a small toaster), and uses molecular technology, which is valued by clinicians and the scientific community for its high degree of accuracy. ID NOW is already the most widely available molecular point-of-care testing platform in the U.S. today.

"The COVID-19 pandemic will be fought on multiple fronts, and a portable molecular test that offers results in minutes adds to the broad range of diagnostic solutions needed to combat this virus," said Robert B. Ford, president and chief operating officer, Abbott. "With rapid testing on ID NOW, healthcare providers can perform molecular point-of-care testing outside the traditional four walls of a hospital in outbreak hotspots."

Abbott will be making ID NOW COVID-19 tests available next week to healthcare providers in urgent care settings in the U.S., where the majority of ID NOW instruments are in use today. The company is working with the Administration to deploy tests to areas where they can have the greatest impact.

The arrival of the Abbott ID NOW COVID-19 test comes a week after the company launched its Abbott m2000 RealTime SARS-CoV-2 EUA test, which runs on the m2000 RealTime System located in hospital and reference labs around the world. Between the two platforms, Abbott expects to produce about 5 million tests per month.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/252280 .

Major Points in Table of Contents:

Global Cardiac Arrest Treatment Market Report 2020

1 Cardiac Arrest Treatment Product Definition

2 Global Cardiac Arrest Treatment Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Cardiac Arrest Treatment Shipments

2.2 Global Manufacturer Cardiac Arrest Treatment Business Revenue

2.3 Global Cardiac Arrest Treatment Market Overview

3 Manufacturer Cardiac Arrest Treatment Business Introduction

3.1 Amgen, Inc. Cardiac Arrest Treatment Business Introduction

3.2 Pfizer, Inc. Cardiac Arrest Treatment Business Introduction

3.3 Johnson & Johnson Cardiac Arrest Treatment Business Introduction

3.4 Novartis AG Cardiac Arrest Treatment Business Introduction

3.5 Bristol-Myers Squibb Company Cardiac Arrest Treatment Business Introduction

3.6 Abbott Cardiac Arrest Treatment Business Introduction

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.